文献速递生殖医学

精子自身免疫程度与自然及宫腔内人工授精辅助活产的关系

Relationship between natural and intrauterine insemination-assisted live births and the degree of sperm autoimmunisation.
PubMed 文献 · Hum Reprod · 2020-01-01

该回顾性队列研究纳入108例IgG-MAR试验≥50%阳性的不育男性,分为100%阳性组和50%-99%阳性组,发现100%阳性组自然活产率显著低于低阳性组(4.5% vs 30.0%,P=0.00001),而宫腔内人工授精(IUI)作为一线治疗在100%阳性组获得36.8%的活产率。

要点

  • 100%阳性MAR试验者自然活产率仅4.5%,显著低于50%-99%阳性者的30.0%。
  • 100%阳性组IUI一线治疗活产率达36.8%,低阳性组IUI活产率26.9%与自然活产率30.0%相近。
  • 性交后试验(PCT)结果越好自然活产率越高(阴性、亚正常、良好分别为6.3%、21.7%、46.2%)。

核心结论

  • 100%阳性MAR试验与不育夫妇自然活产率显著降低相关,但IUI可作为一线治疗成功获得活产。

研究设计与样本

  • 回顾性队列研究,纳入1994年3月至2017年9月期间108例MAR试验≥50%阳性的不育男性。
  • 最终84例(77.8%)完成电话随访并参与分析,其中44例为100%阳性组,40例为50%-99%阳性组。

主要发现

  • 100%阳性组每对夫妇自然活产率为4.5%,显著低于低阳性组的30.0%(P=0.00001)。
  • 两组间仅PCT结局存在显著差异,100%阳性组PCT结果更差。
  • PCT结局(阴性、亚正常、良好)与自然活产率呈正相关(6.3%、21.7%、46.2%,P=0.0005 for trend)。
  • 精子自身免疫程度是自然活产的唯一独立负性预测因素。
  • 100%阳性组中38对夫妇接受IUI一线治疗,获得14例活产(36.8%);低阳性组IUI后活产率为26.9%。

关键数值与推荐

  • WHO推荐通过IgG-MAR试验或免疫珠结合试验筛查抗精子抗体,以50%抗体包被活动精子作为临床相关阈值。
  • 本研究将MAR试验≥50%阳性者分为100%阳性组和50%-99%阳性组进行比较。

临床怎么用

  • IgG-MAR试验应作为基础生育评估的常规项目,因其影响决策。
  • 100%阳性MAR试验可能是不育的唯一原因,可成功采用IUI一线治疗。
  • 低阳性程度可能仅为不育的促进因素,治疗或等待决策还需结合PCT等常规预后因素评估。

局限性

  • 回顾性研究设计,无法排除随访期间影响自然妊娠的未控制变量。
  • 自然活产与IUI后活产的比较可能存在选择偏倚。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

STUDY QUESTION: What is the relationship between the degree of sperm autoimmunisation, as assessed by IgG-mixed antiglobulin reaction (MAR) test, and natural and intrauterine insemination (IUI)-assisted live births? SUMMARY ANSWER: Compared with a lower degree of positivity (50-99%), a 100%-positive MAR test was associated with a much lower occurrence of natural live births in infertile couples, who could be successfully treated with IUI, as first-line treatment. WHAT IS KNOWN ALREADY: The World Health Organization (WHO) has recommended screening for antisperm antibodies, through either the IgG-MAR test or an immunobead-binding test, as an integral part of semen analysis, with 50% antibody-coated motile spermatozoa considered to be the clinically relevant threshold. However, the predictive value of the degree of positivity of the MAR test above such a cut-off on the occurrence of natural pregnancies remains largely undetermined. Furthermore, the effectiveness of IUI in cases of strong sperm autoimmunisation is not yet well-established. STUDY DESIGN, SIZE, DURATION: This was a retrospective cohort study on 108 men with a ≥50%-positive MAR test, where the couple had attended a university/hospital andrology/infertility clinic for the management of infertility from March 1994 to September 2017. PARTICIPANTS/MATERIALS, SETTING, METHODS: The IgG-MAR test was carried out as an integral part of semen analysis. The patients were divided into two groups: 100% and 50%-99%-positive MAR test. The post-coital test (PCT) was performed in all the couples, and IUI was offered as the first-line treatment. Laboratory and other clinical data were retrieved from a computerised database. Data on subsequent pregnancies were obtained by contacting patients over the telephone. MAIN RESULTS AND THE ROLE OF CHANGE: A total of 84 men (77.8%) were successfully contacted by telephone, and they agreed to participate. Of these, 44 men belonged to the group with a 100%-positive MAR test, while 40 showed lower MAR test positivity. The couples with a 100%-positive MAR test showed a natural live birth rate per couple (LBR) that was considerably lower than that observed with a lower degree of positivity (4.5% vs. 30.0%; P = 0.00001). Among the clinical variables, a significant difference between the two groups was observed only for the PCT outcome, which was poor in the 100%-positive MAR test group. Better PCT outcomes (categorised as negative, subnormal and good) were positively associated with the occurrence of natural live births (6.3, 21.7 and 46.2%, respectively; P = 0.0005 for trend), for which the sole independent negative predictor was the degree of sperm autoimmunisation. IUI was performed as the first-line treatment in 38 out of 44 couples with a 100%-positive MAR test, yielding 14 live births (36.8%). In couples with lower MAR test positivity, the LBR after IUI (26.9%) was similar to the natural LBR in this group (30.0%). LIMITATIONS, REASONS FOR CAUTION: Given the retrospective nature of the study, we cannot exclude uncontrolled variables that may have affected natural pregnancies during the follow up or a selection bias from the comparison of natural live births with those after IUI. WIDER IMPLICATIONS OF THE FINDINGS: The routine use of the IgG-MAR test in the basic fertility workup is justified as it influences decision making. A 100%-positive IgG-MAR test can represent the sole cause of a couple's infertility, which could be successfully treated with IUI. On the other hand, a lower degree of positivity may only represent a contributing factor to a couple's infertility, and so the decision to treat or wait also depends on the evaluation of conventional prognostic factors including the PCT outcome. STUDY FUNDING, COMPETING INTEREST(S): This study was supported by PRIN 2017, Ministero dell'Università e della Ricerca Scientifica (MIUR), Italy. On behalf of all authors, the corresponding author states that there is no conflict of interest. TRIAL REGISTRATION NUMBER: N/A.

来源:Hum Reprod,查看原文。版权归原作者所有。

引用

  1. Barbonetti A, Castellini C, D'Andrea S, et al. Relationship between natural and intrauterine insemination-assisted live births and the degree of sperm autoimmunisation. Hum Reprod. 2020. PMID: 32358600. doi:10.1093/humrep/deaa070

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。